ARCHIVES

ODAC Votes 13:0 For Approving Perjeta

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

Funding Opportunities

December 13, 2002

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

November 28, 2014

In Brief: Training Act Requires 75% Fr Institutional Grants, Rest For Individuals Fellowships

September 27, 1974

Tobacco Use Research Centers Funded

October 22, 1999